Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: phoenix_rising who wrote (1709)	3/1/2016 9:39:13 AM
From: eico20	Read Replies (1) \| Respond to of 2026

it's in Boston so I'll try to talk to them, again alot of good that's done

To: phoenix_rising who wrote (1709)	3/1/2016 2:48:55 PM
From: Mirror Image	Read Replies (1) \| Respond to of 2026

It is a perfect opportunity for a press release pre-market that morning and then a Conference Call that same day after market to touch on the Fispemifene results on top of updating the Vitaros figures. I can see this happening. I had the first 3 weeks of March as a timeframe for Fispemifene results. In my opinion, it would be before the Year End Conference Call that we should have somewhere pretty soon. I I also believe they will be presenting at the Roth Capital Conference mid March.